A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
Clinical trial NCT04004611 · COMPLETED
Trial details
- NCT number
- NCT04004611
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2023-03-15
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.